Samina Hamied of Cipla is the new VP of the IPA for 2021-23
Appointment

Samina Hamied of Cipla is the new VP of the IPA for 2021-23

Cipla is a leading global pharma company

  • By IPP Bureau | October 04, 2021

Samina Hamied, Executive Vice Chairman, Cipla has been appointed as the new Vice President of the Indian Pharmaceutical Alliance for 2021-23

Samina Hamied is the Executive Vice-Chairperson of Cipla and represents the third generation of the founding family of Cipla. Cipla is a leading global pharmaceutical company with 46 manufacturing sites around the world that produce over 50 dosage forms and more than 1,500 products that cater to more than markets. Cipla’s strengths in the respiratory, antiretroviral, urology, cardiology, anti-infective and CNS segments are well-known. Hamied said “Pleased to receive this opportunity to play a pivotal role in shaping the healthcare ecosystem and unlocking significant growth opportunities. I am looking forward to working collaboratively with all stakeholders of the industry to ensure sustainable, resilient and agile operations and create a positive difference in the lives of patients.”

Upcoming E-conference

Other Related stories

Startup

Digitization